Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT001 for moderate to severe crow's feet lines
NCT01940991Phase 2Completed
- Sponsor
- Revance Therapeutics
- Start
- Aug 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RT001, sponsored by Revance Therapeutics. Started Aug 2013; status: completed.
02
Drugs
RT001
Beyond the preview
Go deeper on NCT01940991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01940991.